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Here we describe a new approach for facilitating a mechanistic 
understanding of high throughput Caco-2 permeability data.  
A large, uniform set of permeability data is reported, 
generated under two pH conditions.  We found that this data 
could be successfully modelled, and that a mechanistic 
understanding of apparent permeability could be gained. 
Introduction 
The Caco-2 cell model is widely used in drug discovery and 
development for the determination of permeability characteristics of 
potential drug candidates.  Reports have demonstrated its utility in the 
prediction of oral absorption of drugs in man based on permeability 
across Caco-2 monolayers1.  
Several previous studies of the modelling of permeability across Caco-
2 monolayers have been reported2,3,4,5,6,7,8,9. The main purpose of such 
modelling was to successfully predict the screening result, and in some 
cases to act as a pre-screen prior to the measurement. Typically, 
researchers found that physicochemical properties are essential to 
define Caco-2 permeability, but often the relative contribution of each 
property was not explored. 
High throughput (HT) Caco-2 methods are now available for testing of 
high numbers of compounds in discovery phases, often replacing 
PAMPA as the screening method of choice.  We have developed a HT 
Caco-2 permeability assay capable of running 96 samples in a single 
experiment, using simultaneous quantification of samples from A-B 
and B-A directions.  A large dataset of apparent permeability 
coefficient (Papp) values have been generated, in order to validate the 
assay, and to compare against reported human intestinal absorption 
measurements1.  
A critical analysis of the relative contribution of molecular properties 
governing the permeability process could be used as a tool for 
comparing methods set-up in different labs, as well as for helping to 
guide medicinal chemistry programs.  For the aforementioned reasons 
we were interested in mining this dataset to understand further the 
fundamental drivers and their relative contribution of permeability in 
HT Caco-2 assays.  Following recent guidance for QSAR modelling10, 
we set out to find a mechanistic interpretation, with clear relation to 
physicochemical properties. 
Block Relevance (BR) analysis is a new tool that produces an easy-to-
read mechanistic interpretation of PLS models based on VolSurf+ (VS+) 
descriptors.11, 12, 13 The basic concept of VolSurf is to extract the 
information present in 3D molecular field maps into a few quantitative 
numerical descriptors which are easy to understand and to interpret. 
We have successfully applied the technique to distinguish 
chromatographic indexes11,12  and to characterize the dominant effect 
of Hydrogen Bond Donor (HBD) solute properties in the difference 
between log P measurements in two different systems (log Poct-tol)13. BR 
analysis mandates the organization of the VS+ descriptors into six 
blocks (namely, Size, Water, DRY, N1, O and Others) which enable a 
straightforward understanding of the investigated phenomenon, in 
this case cell-based permeability. We sought to investigate from BR 
outputs, whether permeability across Caco-2 monolayers is driven 
predominantly by a compounds hydrophobicity or hydrogen bonding 
properties. 
This paper reports a large and uniform set of original apical to 
basolateral permeability data across Caco-2 monolayers and highlights 
which intermolecular forces drive permeability. These results could be 
used to aid medicinal chemistry design, and also provide an additional 
validation criteria to evaluate HT Caco-2 permeability assays, based on 
the balance of the intermolecular forces governing the system.  
Results and Discussion 
Papp was determined in Caco-2 cells from equation 1, where dQ/dt is the 
rate of permeation of the drug across the cells, C0 is the donor 
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compartment concentration at time zero and A is the area of the cell 
monolayer.   
𝐏𝐚𝐩𝐩 =  (
𝐝𝐐/𝐝𝐭
𝐂𝟎 × 𝐀
) 
Equation 1. 
Two different pH conditions for the donor compartment (6.5 and 7.4) 
were used, producing two sets of data; Papp 6.5/7.4 (n = 85) and Papp 
7.4/7.4 (n = 54), respectively. These represent two of the most 
commonly screened conditions for Caco-2 permeability. An acidic 
apical compartment can be used to model the upper small intestine, for 
which the pH6.5/7.4 screening condition is employed.  However many 
researchers prefer to use pH7.4 in both chambers to eliminate the 
effect of a pH gradient.  Test compound permeability was assessed in 
duplicate, and the mean Papp values, along with standard deviations are 
reported in the supporting information.   
The dataset was checked for its chemical diversity through the analysis 
of some physicochemical properties (see supporting information). 
Results showed that a broad range of physicochemical properties was 
covered. 
The Papp 6.5/7.4 dataset was split in a training (n = 54) and a test set (n = 
31). The training set was designed to include drugs for which both Papp 
6.5/7.4 and Papp 7.4/7.4 were available.  We verified the relationship 
between the two series of data (Papp 6.5/7.4 and Papp 7.4/7.4), and found 
a very good correlation (R2 = 0.93, not shown), with no significant 
outliers. 
Before proceeding with modeling we made an assumption regarding 
molecular flexibility. When VS+ processes the data, it associates each 
compound to the lipophilicity value of an “average” conformer built 
internally by an ad-hoc algorithm. In general terms this is a suitable 
protocol because one can assume that the “average” conformer 
represents all conformers energetically accessible. However this 
assumption no longer holds when the molecule in question has strong 
propensity to form intra-molecular hydrogen bonds, since the 
molecule is then forced into a specific conformation. In this case a very 
different profile of VolSurf+ descriptors could be obtained from the 
conformers without intra-molecular hydrogen bonds.13 In the process 
of crossing the cell membrane, the molecules experience a wide variety 
of environments (membrane interaction, diffusion, flip-flop 
mechanism).14, 15 Conformation may vary greatly during the membrane 
passage and thus the use of an average conformation would seem 
reasonable.  
Finally we made some preliminary tests that enabled the identification 
of three outliers: acarbose, digoxin and adefovir. Acarbose and digoxin 
both possess a tri-saccharide chain containing multiple hydrogen bond 
donors and acceptors and are hence outliers in terms of these 
descriptors. Adefovir could have parameterisation issues in the GRID 
force field applied by VS+ (see Experimental Section). All three outliers 
were removed from the study. 
Modeling log Papp (6.5/7.4) 
Experimental log Papp values of the compounds belonging to the 
training set (n = 54) were imported into VS+ as response variables (Y) 
and a relation between Y and the 82 VS+ descriptors (X) was sought 
using the PLS algorithm implemented in the software. A model was 
found (Table 1) and the correlation between calculated vs experimental 
values is shown in Fig. 1 (filled circles). 
 
Activity N Validation LVs R2 Q2 RMSE 
log Papp 
6.5/7.4 
54 LOO 3 0.72 0.50 0.61 
54 RG 3 0.71 0.49 0.62 
log Papp 
7.4/7.4 
54 LOO 3 0.79 0.57 0.56 
54 RG 3 0.78 0.56 0.57 
log 
D7.4 
54 LOO 3 0.70 0.52 0.80 
54 RG 3 0-70 0.50 0.80 
Table 1. PLS statistical results 
(N = number of observations, R2 = cumulative determination coefficient, Q2 
= cross-validated correlation coefficient, LV = number of latent variables, 
RMSE = root mean square error, LOO = Leave One Out, RG = Random 
Group)) 
The validation of the models was firstly performed by means of an 
internal procedure (see experimental section). Satisfactory statistical 
results were obtained (Table 1).  
Following recently published QSAR guidelines10 we also performed an 
external validation of the PLS model using the test set. Predictions are 
shown in Fig. 1 (empty circles) and support the statistical stability of the 
model. 
 
Figure 1. Experimental log Papp (6.5/7.4) of the drugs belonging to the training set 
versus the predicted values (filled circles) and experimental log Papp (6.5/7.4) of 
the drugs belonging to the test set versus the predicted values (empty circles).  
Modeling log Papp (7.4/7.4) 
The same procedure described above for log Papp (6.5/7.4) was also 
performed for log Papp (7.4/7.4). The validation of the models was 
performed by means of the internal procedures alone (LOO, RG and 
dataset with a randomized Y order). Satisfactory statistical results were 
obtained (Table 1), slightly better than those obtained when modeling 
log Papp (6.5/7.4). 
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Interpretation of the PLS models by Block Relevance 
(BR) analysis 
A mechanistic interpretation based on the nature of the interaction of 
the solute with the environment, represented by some tailored probes, 
‘blocks’ is defined by the GRID methodology16, 17, 18. Their significance is 
summarized in Fig. 2, as proposed in previous studies12.  
 
 
Figure 2. Block definition: the name of the block is in bold, the solute’s property 
described by the block in italics. The color code is maintained throughout the 
study. 
 
The BR analysis results are graphically reported in Fig.3A and Fig.3B. 
 
Figure 3. BR analysis graphical output: A) log Papp (6.5/7.4); B) log Papp (7.4/7.4); C) 
calculated log Doct 7.4. The blocks’ definition is reported in Figure 2.  
Blocks with a positive weighting indicate how much the property 
increases permeability, whereas those with negative weighting (e.g. 
red block) indicate how much the property decreases permeability. The 
presence of positive and negative components for most blocks is partly 
due to noise and partly due to the inter-correlation of descriptors.  
Figure 3A (log Papp 6.5/7.4) and 3B (log Papp 7.4/7.4) outline the major role 
(about 35% of the weight of all blocks) played by HBD solute properties 
(red bars) to govern Caco-2 permeability. The role of HBA solute groups 
(blue bars) by contrast is modest (about 15%) and similar to all 
remaining blocks.  
Very little difference was observed between the two data sets in terms 
of the output from BR analysis.  A possible reason for this is the dataset 
does not contain a large number of compounds that we would expect 
to have different charge states at pH 6.5 versus 7.4. 
It is often reported in the literature that permeability can be modeled 
by log D7.4oct, but this analysis would seem to suggest that logD alone 
is a poor surrogate. To investigate further, we calculated log D7.4oct 
for all the drugs, and plotted against log Papp 6.5/7.4, Figure 4. 
 
 
Figure 4. The relationship between log Papp (6.5/7.4); and calculated log Doct 7.4. 
The weak correlation observed suggests that the balance of 
intermolecular forces that govern log D7.4oct and log Papp 6.5/7.4 is very 
different. To confirm this hypothesis we again used BR analysis. 
The log D7.4oct values of the training set were imported into VS+ as 
response variables (Y) and a relation between Y and the 82 VS+ 
descriptors (X) was sought using the PLS algorithm as previously 
described. Statistics were good (see table 1) and thus we submitted 
PLS output to BR analysis. The graphical output is shown in Fig. 3C and 
shows how the balance of intermolecular interactions governing log 
Doct 7.4 is completely different from that governing log Papp. (Fig. 3A 
and 3B) This supports the finding that lipophilicity is not the dominant 
factor for understanding log Papp. In fact, a large drug size (green block) 
generally causess an increase in log Doct 7.4 (Fig. 3C, positive sign) but 
a decrease in log Papp (Fig. 3A and 3B, negative sign). Moreover HBA 
solute properties (blue bars) are important for logD7.4 but not for log 
Papp as previously discussed. 
Conclusions 
This analysis has shown that the most important factors for 
understanding the physicochemical drivers for HT Caco-2 permeability 
are hydrogen bond donor properties.  No consideration has been given 
in this analysis to the contribution of active transport mechanisms and 
the effect they may have on Papp.  Clearly such factors are of great 
importance when describing permeability in Caco-2 cells, and 
compounds which display significant active efflux will inevitably have a 
low apical to basolateral Papp value which is not fully explained by an 
analysis of bulk physicochemical properties such as this.  These 
interactions may, in part be accounted for in the analysis, but we have 
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not attempted to include sufficient compounds in the dataset to model 
active efflux.  The conclusions should therefore be interpreted as a bulk 
property basis, and not in a purely predictive fashion.  Indeed, we would 
not expect compounds with specific interactions to be well predicted 
by this model.  However, we would expect the same principles to apply 
to the passive aspect of such compounds permeability.   
We now intend to extend this analysis to assess the main drivers for 
human intestinal absorption, and to verify (or otherwise) that the same 
descriptors and directionalities are driving this phenomenon as Caco-2 
permeability. 
Experimental  
All reagents were purchased from Sigma-Aldrich unless otherwise 
stated.  Hanks Balanced Salt Solution (HBSS) buffer was supplemented 
with 25mM HEPES and 4.45 mM glucose and the pH adjusted to 7.4.  
HBSS buffer was supplemented with 10 mM MES and 4.45mM glucose, 
and the pH adjusted to 6.5. 
Caco-2 cells (ATCC) were seeded onto Millicell 96 well plates (Millipore, 
MA, USA) at 1 x 105 cells/cm2. The cells were cultured in DMEM and 
media was changed every two or three days for 20 days for confluent 
cell monolayer formation.  Cell culture and assay incubations were 
carried out at 37°C, 5% CO2 with a relative humidity of 95%.  On the day 
of the experiment, the monolayers were prepared by rinsing both 
apical and basolateral surfaces twice with HBSS at the desired pH.  Cells 
were incubated with HBSS at the desired pH in both apical and 
basolateral compartments for 40 minutes to stabilise physiological 
parameters. 
The dosing solutions were prepared by diluting test compound with 
assay buffer to give a final test compound concentration of 10 µM (final 
DMSO concentration of 1 % v/v).  The fluorescent integrity marker 
lucifer yellow was also included in the dosing solution.  Analytical 
standards were prepared from test compound DMSO dilutions and 
transferred to buffer, maintaining a 1 % v/v DMSO concentration. For 
assessment of A-B permeability, HBSS was removed from the apical 
compartment and replaced with test compound dosing solution.  The 
apical compartment insert was then placed into a companion plate 
containing fresh buffer (containing 1 % v/v DMSO).  At 120 minutes the 
apical compartment inserts and the companion plates were separated 
and apical and basolateral samples diluted for analysis.   
Test compounds were quantified by LC/MS/MS analysis using an 8 
point calibration with appropriate dilution of the samples.   The 
integrity of the monolayer throughout the experiment was checked by 
monitoring lucifer yellow permeation using fluorimetric analysis.  If 
lucifer yellow permeation was found to be above pre-defined 
thresholds, the result was rejected and repeated. 
VS+ models were built by submitting the SMILES codes of the 
compounds to VS+ (version 1.0.7, http://www.moldiscovery.com) using 
default settings and four probes (OH2, DRY N1 and O probes that 
mimic respectively water, hydrophobic, HBA and HBD properties of the 
environment). PCA and PLS tools implemented in VS+ were used. BR 
analysis was performed as described elsewhere.11, 12, 13 
pKa and log D7.4 calculations were performed with MoKA (v.2.5.4, 
www.moldiscovery.com). 
Processing was done on a two 8 cores Xeon E5 at 3.3GHz CPUs and 
128GB of RAM. 
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